###begin article-title 0
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver
###end article-title 0
###begin p 1
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 525 529 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 538 539 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</italic>
###xml 920 921 920 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1294 1295 1294 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1302 1303 1302 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1412 1413 1410 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1419 1420 1417 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1739 1746 1737 1744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 770 775 <span type="species:ncbi:9606">human</span>
###xml 789 794 <span type="species:ncbi:9606">human</span>
Genome-wide association studies have identified a number of signals for both Type 2 Diabetes and related quantitative traits. For the majority of loci, the transition from association signal to mutational mechanism has been difficult to establish. Glucokinase (GCK) regulates glucose storage and disposal in the liver where its activity is regulated by glucokinase regulatory protein (GKRP; gene name GCKR). Fructose-6 and fructose-1 phosphate (F6P and F1P) enhance or reduce GKRP-mediated inhibition, respectively. A common GCKR variant (P446L) is reproducibly associated with triglyceride and fasting plasma glucose levels in the general population. The aim of this study was to determine the mutational mechanism responsible for this genetic association. Recombinant human GCK and both human wild-type (WT) and P446L-GKRP proteins were generated. GCK kinetic activity was observed spectrophotometrically using an NADP+-coupled assay. WT and P446L-GKRP-mediated inhibition of GCK activity and subsequent regulation by phosphate esters were determined. Assays matched for GKRP activity demonstrated no difference in dose-dependent inhibition of GCK activity or F1P-mediated regulation. However, the response to physiologically relevant F6P levels was significantly attenuated with P446L-GKRP (n = 18; P </= 0.03). Experiments using equimolar concentrations of both regulatory proteins confirmed these findings (n = 9; P < 0.001). In conclusion, P446L-GKRP has reduced regulation by physiological concentrations of F6P, resulting indirectly in increased GCK activity. Altered GCK regulation in liver is predicted to enhance glycolytic flux, promoting hepatic glucose metabolism and elevating concentrations of malonyl-CoA, a substrate for de novo lipogenesis, providing a mutational mechanism for the reported association of this variant with raised triglycerides and lower glucose levels.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C1">1</xref>
###xml 154 158 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C2">2</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C2">2</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C4">4</xref>
A recent genome-wide association (GWA) scan identified GCKR as a potential locus for modulating triglyceride and fasting plasma glucose (fpg) levels (1). GCKR encodes glucokinase regulatory protein (GKRP), and following fine mapping attributed the signal to the common non-synonymous SNP rs1260326 (c.1403 C > T, p.P446L, MAF 34%) (2). Subsequent population-based studies have replicated the association of this variant with triglyceride and fpg levels. Individuals homozygous for the risk allele (L) have on average a 0.15 mmol/l increase in triglyceride and a 0.06 mmol/l reduction in fpg levels compared with individuals with two copies of the wild-type (WT) allele (P) (2-4). The mutational mechanism behind this genetic association is currently unknown. However, unlike many signals arising from GWA studies, there is a non-synonymous SNP in a strong biological candidate gene driving the genetic association, thus facilitating functional studies. Even with such tractable variants, identifying the mutational mechanism for common risk alleles presents a challenge due to their small physiological effects. It is therefore essential that the 'correct' assays are selected and performed if these small differences in protein function are to be observed.
###end p 3
###begin p 4
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C5">5</xref>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C6">6</xref>
###xml 398 399 398 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 400 401 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C9">9</xref>
Glucokinase (GCK) is a key regulator of glucose storage and disposal in the liver. GKRP regulates GCK activity competitively with respect to the substrate glucose (5,6). GKRP action is in turn controlled by the phosphate esters fructose 6- and fructose 1-phosphate (F6P and F1P), which compete with each other for binding, and enhance or inhibit the action of the regulatory protein, respectively (7-9).
###end p 4
###begin p 5
###xml 108 110 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C10">10</xref>
###xml 111 113 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C12">12</xref>
###xml 156 160 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 200 202 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C11">11</xref>
###xml 203 205 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C12">12</xref>
###xml 280 284 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 384 386 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C10">10</xref>
###xml 446 450 437 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 465 470 <span type="species:ncbi:9606">human</span>
There is some controversy in the literature as to whether GKRP also regulates GCK in pancreatic beta-cells (10-12). The vast majority of studies state that GCKR is not expressed in rodent beta-cells (11,12). However, there is evidence from one study that an alternatively spliced GCKR variant is expressed in the beta-cells of rodents and represents the major isoform in this tissue (10). To date, no studies have been reported which investigate GCKR expression in human pancreatic islets.
###end p 5
###begin p 6
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C13">13</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C14">14</xref>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C14">14</xref>
###xml 583 587 583 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gkrp</italic>
###xml 638 641 638 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gck</italic>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C11">11</xref>
###xml 773 780 773 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 800 803 800 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gck</italic>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C13">13</xref>
###xml 201 206 <span type="species:ncbi:9606">human</span>
###xml 597 601 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 807 810 <span type="species:ncbi:10116">rat</span>
Biological evidence to support the association of these phenotypes with the GCKR SNP comes from both cellular and rodent models (13,14). Counter intuitively, Slosberg et al. over expressed GCKR in the human liver cell line HepG2 and showed an increase in GCK activity and expression at the protein level. From this, they suggested that GKRP as well as inhibiting GCK activity, also has a paradoxical role in extending GCK half-life by binding to and stabilizing the enzyme, thus protecting it from degradation (14). This finding is supported by data from both homo- and heterozygous gkrp knockout mice which display a marked reduction in gck expression and reduced GCK enzymatic activity under saturating glucose concentrations (11). At least one study has also shown that in vivo over-expression of gck in rat hepatocytes led to a drop in plasma glucose levels with a corresponding increase in circulating triglycerides (13). Therefore, findings from both groups suggested that (i) GKRP expression has a direct affect on GCK activity and (ii) there is a link between GCK activity and plasma glucose/circulating triglyceride levels.
###end p 6
###begin p 7
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C9">9</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C15">15</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C16">16</xref>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C9">9</xref>
###xml 580 581 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 582 584 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C17">17</xref>
###xml 854 855 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 201 204 <span type="species:ncbi:10116">rat</span>
###xml 560 563 <span type="species:ncbi:10116">rat</span>
###xml 568 573 <span type="species:ncbi:9606">human</span>
###xml 594 599 <span type="species:ncbi:9606">human</span>
###xml 714 717 <span type="species:ncbi:10116">rat</span>
###xml 734 739 <span type="species:ncbi:9606">human</span>
A number of studies investigating the interaction of GCK and its regulatory protein have been reported but due to technical difficulties in purifying human recombinant GKRP, all of these have used the rat isoform (9,15,16). One of these studies investigated the effect of rodent P446L-GKRP on GCK activity and reported no differences in the inhibitory ability of the variant protein or its response to phosphate esters compared with WT (9). However, despite their high sequence homology (approximately88%), there are important differences in the regulation of rat and human GKRP (7,17). First, human regulatory protein inhibits GCK even in the absence of F6P, an affect not observed with the same concentration of rat GKRP. Secondly, human regulatory protein was shown to have a higher affinity for this phosphate ester compared with the rodent protein (7).
###end p 7
###begin p 8
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 354 357 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 271 276 <span type="species:ncbi:9606">human</span>
The aims of this study were therefore, first, to investigate the affect of both human WT and P446L-GKRP on human GCK activity and secondly, to determine whether their regulation by phosphate esters was altered. Finally, we aimed to establish whether GCKR is expressed in human pancreatic islets, and if so, to look at this expression relative to that of GCK.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
WT and P446L-GKRP both inhibit GCK activity
###end title 10
###begin p 11
###xml 132 148 132 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 296 297 296 297 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP357F1">1</xref>
###xml 501 502 501 502 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 132 148 <span type="species:ncbi:562">Escherichia coli</span>
To assess the inhibitory function of our purified recombinant human WT and P446L-GKRP proteins following heterologous expression in Escherichia coli, one unit of each regulatory protein was used in assays to study competitive inhibition of GCK activity over a glucose concentration range (0-100 mm). Figure 1A demonstrates that GCK activity is inhibited with both GKRPs (each data point being plotted as a percentage of the negative control in which GKRP was absent and glucose concentration was 100 mm), establishing that both WT and P446L proteins are functional. These results also show no difference between the ability of WT and variant regulatory protein to inhibit GCK in the absence of the phosphate esters F1P and F6P.
###end p 11
###begin p 12
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 282 283 282 283 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 417 418 417 418 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 529 530 529 530 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 535 536 535 536 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 621 622 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 689 690 689 690 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 787 788 787 788 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 940 941 940 941 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 951 952 951 952 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1151 1152 1151 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1167 1168 1167 1168 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1338 1339 1338 1339 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1341 1342 1341 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) Competitive inhibition of GCK using equivalent activities of WT and P446L-GKRP (n = 24). Competitive inhibition of 10 m U/ml GCK by one GKRP unit (WT=black circles, P446L=white circles, negative control=black triangles) was observed over a glucose concentration range of 0-100 mm. Each data point was plotted as a percentage of the negative control in which GKRP was absent and glucose concentration equaled 100 mm. Statistical analysis revealed no difference between the intrinsic inhibitory capacity of WT and P446L-GKRP. (B and C) Competitive inhibition of GCK using equimolar concentrations of WT and P446L-GKRP (n = 3). GCK activity was assayed in the presence of 0, 100 and 150 nm WT (black circles) and P446L (white circles) GKRP, over a glucose concentration range of 0-100 mm. Each data point was plotted as a percentage of the negative control in which GKRP was absent (black triangles) and glucose concentration equaled 100 mm. At 100 nm GKRP, there was statistically no difference between the responses of the two regulatory proteins (although it was noted that the variance of this data was larger than seen for other experiments and n = 3). At 150 nm GKRP, statistical analysis showed the intrinsic inhibitory capacity of P446L-GKRP to be significantly lower than that of the WT regulatory protein at [glucose] over 25 mm (P </= 0.03).
###end p 12
###begin p 13
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP357F1">1</xref>
###xml 160 161 160 161 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 180 181 180 181 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 275 276 275 276 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 295 296 295 296 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 361 362 361 362 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 641 642 637 638 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 672 673 666 667 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 704 705 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
To further compare GKRP activity, competitive inhibition assays were repeated at fixed concentrations of both GKRP proteins (n = 3) as shown in Figure 1B (100 nm GKRP) and C (150 nm GKRP). These data also demonstrate no difference between the two regulatory proteins at 100 nm. However, at 150 nm, P446L-GKRP is less inhibitory than WT at concentrations of 25 mm glucose and above (P </= 0.03). Ki (inhibitor dissociation constants) were calculated from Dixon plots of 1/GCK activity versus [GKRP] for the equimolar concentration experiments (). The Ki values did not significantly differ between the two regulatory proteins (24.0 +/- 40.7 nm for WT versus 23.1 +/- 40.8 nm for P446L-GKRP; mean +/- SEM; P = 1).
###end p 13
###begin p 14
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C18">18</xref>
###xml 98 101 98 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</sub>
###xml 182 183 182 183 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 292 293 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 309 312 301 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0.5</sub>
Our data are consistent with GKRP acting as a competitive inhibitor of GCK activity (18). The KcatGCK (maximal specific activity of GCK) remained unchanged in the presence of 0-150 nm regulatory protein (51.8 +/- 1.6 to 51.9 +/- 6.9 for WT versus 46.8 +/- 0.7 to 53.4 +/- 3.6 for P446L-GKRP; n = 3), and the S0.5 (glucose concentration needed for half maximal rate) was raised with increasing concentrations of both GKRPs (8.7 +/- 0.2 to 16.8 +/- 1.3 for WT versus 8.0 +/- 0.3 to 18.2 +/- 1.1 for P446L-GKRP).
###end p 14
###begin title 15
F1P increases GCK activity with both WT and P446L-GKRP
###end title 15
###begin p 16
###xml 191 192 187 188 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 199 200 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP357F2">2</xref>
###xml 422 423 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 430 431 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data obtained using comparable activities of regulatory protein demonstrated the expected reduction in GKRP-mediated inhibition of GCK activity across a F1P concentration range of 0-500 microm (Fig. 2A). This GKRP-mediated inhibition was decreased by the same extent for both WT and P446L-GKRP (53.7 +/- 1.1 to 92.8 +/- 1.2% GCK activity for WT versus 55.7 +/- 1.5 to 93.6 +/- 1.4% GCK activity with P446L; means +/- SEM; n = 18; P > 0.1).
###end p 16
###begin p 17
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 7 8 7 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 193 194 193 194 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 225 226 225 226 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 237 238 237 238 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 248 249 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 284 285 280 281 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 547 548 539 540 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 554 555 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 568 576 558 566 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apparent</sub>
###xml 712 713 696 697 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 746 747 724 725 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 787 788 759 760 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 821 822 787 788 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 853 854 817 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A and B) F1P negatively modulates both WT and P446L-GKRP-mediated inhibition of GCK, leading indirectly to an increase in enzyme activity. Inhibition of 10 m U/ml GCK by (A) one GKRP unit, 5 mm glucose (n = 18) and (B) 100 nm GKRP, 10 mm glucose (n = 3) was observed over 0-500 microm F1P (black circles=WT, white circles=P446L). GCK activity was plotted as a percentage of that obtained in the absence of either regulatory protein. Statistical analysis revealed no difference in response of WT and P446L-GKRP to F1P up to and including 500 microm F1P (P >/= 0.1). Kiapparent from Dixon plots of [F1P] versus 1/GCK activity did not significantly differ between the two regulatory proteins (A) 31.2 +/- 4.3 microm for WT versus 24.9 +/- 2.0 microm for P446L-GKRP, (B) 54.0 +/- 10.8 microm for WT versus 46.3 +/- 4.2 microm for P446L-GKRP; mean +/- SEM; P >/= 0.1.
###end p 17
###begin p 18
###xml 211 212 207 208 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 286 287 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 293 294 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 377 378 365 366 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 389 390 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP357F2">2</xref>
Experiments using fixed concentrations of both WT and variant regulatory protein confirmed that there was no difference in F1P-mediated inhibition of the two GKRPs at concentrations up to and including 500 microm of phosphate ester (92.5 +/- 2.6% for WT versus 90.1 +/- 1.8% for P446L; n = 9; P = 0.2), despite the initial difference in intrinsic inhibitory capacity at 0 microm F1P (Fig. 2B).
###end p 18
###begin p 19
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 192 200 192 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apparent</sub>
###xml 336 344 336 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apparent</sub>
###xml 434 442 434 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apparent</sub>
###xml 572 573 566 567 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 606 607 594 595 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 624 625 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 681 682 663 664 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 715 716 691 692 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 733 734 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 990 991 950 951 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1080 1081 1024 1025 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
It has been suggested previously that F1P causes an increase in GCK activity by promoting dissociation of the GKRP:GCK complex (7). Therefore the 'apparent' inhibitor dissociation constant (Kiapparent) would be expected to increase upon addition of F1P, as regulatory protein dissociation from the enzyme is promoted. In our studies, Kiapparent from Dixon plots of 1/GCK activity versus [F1P] reflected this. Also, these calculated Kiapparent values did not significantly differ between the two regulatory proteins when using either comparable activity (24.5 +/- 2.0 microm for WT versus 31.2 +/- 4.3 microm for P446L-GKRP; P = 0.1) or equimolar concentrations (54.0 +/- 10.8 microm for WT versus 46.3 +/- 4.2 microm for P446L-GKRP; P = 0.5), suggesting a similar dissociation of both regulatory proteins from GCK in response to F1P. This was also corroborated by observing the [F1P] that caused reversal of GCK inhibition by half (i.e. 75% enzyme activity), which was approximately15 microm F1P for both GKRPs in the matched activity experiments, and approximately15 and 20 microm F1P for P446L and WT-GKRP, respectively, in the comparable concentration experiments.
###end p 19
###begin title 20
Differences in F6P-mediated regulation of P446L-GKRP compared with WT
###end title 20
###begin p 21
###xml 42 43 38 39 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 140 141 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP357F3">3</xref>
###xml 324 325 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 326 327 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C9">9</xref>
###xml 328 330 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C18">18</xref>
###xml 535 536 527 528 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 703 704 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 711 712 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 773 774 751 752 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 800 801 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP357F3">3</xref>
GCK activity was observed over 0-500 microm F6P in the presence of either equal activities or equivalent concentrations of both GKRPs (Fig. 3A and B, respectively). It is well established that F6P-mediated regulation of GKRP leads to enhanced GCK inhibition, and hence a corresponding reduction in observed enzyme activity (7,9,18). This was seen with both WT and P446L-GKRP when using the same activity of regulatory protein, although the reduction in GCK activity was significantly less over the physiologically relevant 25-500 microm F6P concentration range with the variant protein (31.9 +/- 2.6 to 23.3 +/- 1.0% GCK activity versus 28.5 +/- 2.8 to 21.2 +/- 0.8% GCK activity for WT; means +/- SEM; n = 18; P = 0.04, 0.0001, 0.006 and 0.03 for 25, 50, 100 and 500 microm F6P, respectively) (Fig. 3A).
###end p 21
###begin p 22
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 7 8 7 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 166 167 166 167 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 210 211 210 211 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 257 258 253 254 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 563 564 555 556 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 696 697 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 758 759 736 737 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 814 815 788 789 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 827 828 801 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 891 899 865 873 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apparent</sub>
###xml 1050 1052 1016 1018 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m,</sc>
###xml 1067 1068 1033 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1159 1161 1117 1119 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m,</sc>
###xml 1176 1177 1134 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A and B) F6P-mediated regulation of P446L-GKRP is significantly diminished compared with WT regulatory protein. Inhibition of 10 m U/ml GCK by (A) one unit GKRP, 5 mm glucose (n = 18) and (B) 100 nM GKRP, 10 mm glucose (n = 3) was observed over 0-500 microm F6P (black circles=WT, white circles=P446L). GCK activity was plotted as a percentage of that obtained in the absence of regulatory protein. Statistical analysis showed there to be a significant difference between the response of WT and P446L-GKRP (A) over the physiologically relevant range 25-500 microm F6P (31.9 +/- 2.6 to 23.3 +/- 1.0% GCK activity for P446L versus 28.5 +/- 2.8 to 21.2 +/- 0.8% GCK activity for WT; means +/- SEM; P = 0.04, 0.0001, 0.006 and 0.03 for 25, 50, 100 and 500 microm F6P, respectively) and (B) over the entire 0-500 microm F6P range (P < 0.001). Dixon plots of [F6P] versus 1/GCK activity showed Kiapparent was also significantly different between WT and variant regulatory protein in both (A) the comparable activity (31.0 +/- 4.4 versus 21.1 +/- 2.7 microm, respectively; P = 0.05) and (B) equimolar concentration experiments (16.6 +/- 1.7 versus 9.2 +/- 1.0 microm, respectively; P < 0.001).
###end p 22
###begin p 23
###xml 305 306 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 312 313 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 329 330 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP357F3">3</xref>
These results were confirmed in experiments using the same concentration of both regulatory proteins, as there was a significant difference between the response of WT and P446L-GKRP over the entire F6P concentration range (63.7 +/- 2.6 to 14.1 +/- 1.2% versus 71.9 +/- 1.4 to 33.8 +/- 3.1%, respectively; n = 9; P < 0.001) (Fig. 3B).
###end p 23
###begin p 24
###xml 148 156 148 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apparent</sub>
###xml 396 404 396 404 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apparent</sub>
###xml 429 437 429 437 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apparent</sub>
###xml 544 545 538 539 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 571 573 559 561 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m,</sc>
###xml 588 589 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 656 657 638 639 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 682 684 658 660 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m,</sc>
###xml 699 700 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 717 719 693 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 866 868 838 840 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m,</sc>
###xml 917 918 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 954 956 922 924 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m,</sc>
###xml 1008 1009 976 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Increasing F6P concentration has been shown in this study to enhance GKRP-mediated inhibition of GCK activity, and thus it would be expected that Kiapparent would be decreased as a result of reduced dissociation of the inhibitor GKRP from GCK (i.e. 'tighter' enzyme:regulatory protein binding). This was reflected in our data, as Dixon plots of [F6P] versus 1/GCK activity showed a decrease in Kiapparent upon addition of F6P. Kiapparent was also significantly different between WT and P446L-GKRP for both the equal activity (31.0 +/- 4.4 microm versus 21.1 +/- 2.7 microm, respectively; P = 0.5) and equimolar concentration experiments (16.6 +/- 1.7 microm versus 9.2 +/- 1.0 microm, respectively; P < 0.001). The IC50 (concentration of F6P needed to inhibit enzyme activity by 50%) was also significantly different between WT and P446L-GKRP; 23.8 versus 35.0 microm, respectively, for matched activity experiments (P = 0.01), and 25.0 versus 56.3 microm, respectively, for equal concentration experiments (P < 0.001), reflecting a decreased affinity of the variant regulatory protein for F6P in both experiments.
###end p 24
###begin title 25
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
GCKR is highly expressed relative to GCK in human liver, with very low levels in human pancreatic islets
###end title 25
###begin p 26
###xml 309 313 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 318 321 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 454 455 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 470 471 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 494 495 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 517 518 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 542 546 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 610 613 610 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C19">19</xref>
###xml 721 725 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 882 885 882 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 973 974 973 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP357F4">4</xref>
###xml 221 226 <span type="species:ncbi:9606">human</span>
###xml 256 261 <span type="species:ncbi:9606">human</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
###xml 584 589 <span type="species:ncbi:9606">human</span>
###xml 761 766 <span type="species:ncbi:9606">human</span>
Owing to the association of P446L-GKRP with fpg levels, we investigated whether the observed modulation in the P446L-GKRP response to physiologically relevant F6P concentrations could have consequent metabolic affects in human pancreatic islets as well as human liver. To address this question, we quantified GCKR and GCK mRNA levels in appropriate human tissues. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis of liver (n = 1), islets (n = 2), whole pancreas (n = 1) and adipocytes (n = 1) demonstrated that GCKR mRNA is expressed in molar excess in human liver compared with GCK, thus supporting a functional role for the regulatory protein in the hepatocyte (19). Conversely, although GCKR is expressed at very low levels in human islets, whole pancreas and adipocytes (only a tenth of that seen in liver), the much higher relative expression of GCK suggests regulation of this enzyme in these tissues is largely not GKRP mediated (Fig. 4).
###end p 26
###begin p 27
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 9 12 9 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 258 259 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 313 314 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 464 467 464 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:9606">human</span>
GCKR and GCK expression in human liver, pancreas, isolated islets, adipocytes, skeletal muscle and kidney. One microgram RNA was converted to cDNA via RT-PCR and expression of the human GCKR and GCK genes observed via Taqman gene expression analysis. Liver (n = 1), islets (n = 2), pancreas (n=1) and adipocytes (n = 1) were studied (as well as appropriate negative controls). These data show GCKR to be highly expressed in molar excess in the liver compared with GCK. However, in the pancreas and islets, GCK levels are much higher than that of the regulatory protein. In adipocytes, skeletal muscle and kidney both genes are only present at negligible levels.
###end p 27
###begin title 28
DISCUSSION
###end title 28
###begin p 29
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C1">1</xref>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C4">4</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C16">16</xref>
###xml 976 977 976 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 296 301 <span type="species:ncbi:9606">human</span>
###xml 932 937 <span type="species:ncbi:9606">human</span>
In this study, we have performed the first functional characterization of the human P446L-GCKR variant, which has been reproducibly associated with an average 0.15 mmol/l increase in triglyceride and a 0.06 mmol/l decrease in fpg levels in the general population (1-4). Our data demonstrate both human WT and variant regulatory protein to be functional and able to inhibit GCK activity in a dose-dependent manner. Both GKRPs were also equally sensitive to F1P-mediated regulation, which is consistent with that shown previously using rodent proteins (16). However, our analyses have revealed a previously unappreciated change in F6P-mediated modulation of the P446L regulatory protein at physiologically relevant concentrations of this phosphate ester. These results differ from those reported in earlier rodent studies which showed no differences between the two proteins and confirm the important differences in the properties of human GKRP compared with rodent homologues (7).
###end p 29
###begin p 30
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C9">9</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C20">20</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C22">22</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C23">23</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C21">21</xref>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C9">9</xref>
###xml 951 952 951 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C9">9</xref>
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C24">24</xref>
###xml 1207 1208 1207 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C9">9</xref>
###xml 1274 1288 1274 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus laevis</italic>
###xml 1368 1369 1368 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 1370 1371 1370 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C9">9</xref>
###xml 614 617 <span type="species:ncbi:10116">rat</span>
###xml 1259 1264 <span type="species:ncbi:9606">human</span>
###xml 1266 1269 <span type="species:ncbi:10116">rat</span>
###xml 1274 1288 <span type="species:ncbi:8355">Xenopus laevis</span>
The differing responses of the P446L-variant regulatory protein to F1P and F6P may be explained by looking at the binding site of these molecules. The crystal structure of GKRP has not been solved; however, it does have homology with other proteins of known crystal structure, such as the isomerase domain of bacterial glucosamine 6-phosphate synthase (GlmS), which catalyses the conversion of F6P into either glucose 6-phosphate or glucosamine 6-phosphate (9,20-22). This isomerase domain consists of two sugar isomerase sub-domains (23), and analysis of the GlmS crystal structure (21) and functional studies on rat GKRP mutants (9) suggests a single substrate binding site lies between the interface of these two sub-domains. It has also been suggested that GKRP adopts different structural conformations in order to accommodate either F1P or F6P at this single binding site, and only one of these (that favoring F6P-binding) can complex with GCK (9,24). Residue 446 lies between two sequence motifs thought to be involved directly in binding of phosphate esters. As previously reported, mutating certain residues outside of these motifs can still affect binding (and hence regulation of GKRP activity) (9). Also, residue 446 is a conserved proline across human, rat and Xenopus laevis regulatory protein, and all bar the latter are responsive to both F1P and F6P (7,9). Therefore, we propose that residue 446 may not play a direct role in the binding of phosphate esters, but may be important structurally within GKRP. This amino acid substitution could then either reduce the ability of the regulatory protein to adopt the F6P-binding conformation or hinder the F6P-GKRP complex from binding to and inhibiting GCK.
###end p 30
###begin p 31
###xml 556 563 556 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C13">13</xref>
###xml 836 840 836 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 399 403 <span type="species:ncbi:10116">rats</span>
###xml 865 870 <span type="species:ncbi:9606">human</span>
###xml 893 898 <span type="species:ncbi:9606">human</span>
Our data show F6P-mediated regulation of P446L-GKRP to be significantly attenuated compared with WT over a physiological range of F6P concentrations, which ultimately leads to a reduction in GCK-inhibition by the variant regulatory protein. This is predicted to increase glycolytic flux and hence glucose uptake by the liver. This enhanced rate of glycolysis (as is seen with GCK over-expression in rats) may raise levels of other liver metabolites such as malonyl-CoA, increasing triglyceride levels via two mechanisms; first by acting as a substrate for de novo lipogenesis and secondly by inhibiting carnitine-palmitoyl transferase-1 (thus blocking fatty acid oxidation) (13). This perturbation of hepatic metabolism could account for the reduced glucose and raised triglycerides seen in L446-GKRP individuals. However, the very low GCKR mRNA levels detected in human islets (compared with human liver) suggest that GKRP has only a very minor (if any) functional role in the regulation of GCK in the pancreas. Consequently, pancreatic GCK is unlikely to be affected in individuals with this variant regulatory protein confirming that the phenotype observed is driven by a hepatic effect.
###end p 31
###begin p 32
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C25">25</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C26">26</xref>
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C1">1</xref>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C4">4</xref>
###xml 668 671 668 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gck</italic>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C13">13</xref>
###xml 817 820 817 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gck</italic>
###xml 917 920 917 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gck</italic>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C27">27</xref>
###xml 946 948 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C28">28</xref>
Broader implications of these findings regard the alteration of GCK activity to treat diabetes. Aberrant GCK function has been implicated in both monogenic forms of diabetes and in the variation of fpg levels within the general population, and as such it is a well-established therapeutic target (25,26). The initial genetic association data concerning the P446L-GCKR variant (1-4) supported by our functional studies confirm that changing the regulation of GCK activity solely in the liver could alter other hepatic metabolic pathways, thus resulting in an unfavorable lipid profile. This has already been shown in one study in rodents, where over-expressing hepatic gck lowers plasma glucose as well as raising triglyceride levels (13). However, a number of other studies have shown that hepatic over-expression of gck does not always result in an increase in triglycerides, suggesting that the degree of increased gck activity is critical (27,28). As such, potential new therapies targeting GKRP in the liver should be approached with caution.
###end p 32
###begin p 33
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 242 247 <span type="species:ncbi:9606">human</span>
In conclusion, our functional studies demonstrate that altered F6P-mediated GKRP regulation in carriers of the L446 allele explains the association between the common P446L-GCKR variant and higher triglyceride and lower fpg levels in several human populations. This work demonstrates that with suitable functional studies it is possible to establish mutational mechanisms for common variants of modest effect size identified by GWA studies.
###end p 33
###begin title 34
MATERIALS AND METHODS
###end title 34
###begin title 35
Site-directed mutagenesis
###end title 35
###begin p 36
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pfu</italic>
###xml 73 78 <span type="species:ncbi:9606">human</span>
p-FLAG CTC vector (Sigma Aldrich Company Ltd, Gillingham, UK) containing human GKRP coding sequence was kindly supplied by Katy Brocklehurst (7). The P446L mutation was introduced via PCR-based site-directed mutagenesis using Pfu-polymerase (Promega, Southampton, UK) and primers shown in  (Operon Biotechnologies GmbH, Cologne, Germany). Mutant and WT plasmids were then used to transfect BL21 competent cells (Stratagene Europe, Amsterdam, The Netherlands), and DNA obtained using QIAprep Spin Miniprep Kit (Qiagen Ltd, Crawley, UK). Mutant and WT sequences were confirmed via direct sequencing using primers in .
###end p 36
###begin title 37
Protein extraction
###end title 37
###begin p 38
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C29">29</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C30">30</xref>
###xml 619 620 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 823 824 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 851 852 851 852 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 867 868 867 868 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 879 880 879 880 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 901 902 901 902 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 930 931 930 931 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1149 1150 1143 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 479 484 <span type="species:ncbi:9606">human</span>
Glutathione S-transferase-tagged human pancreatic GCK was prepared as described previously (29). The pancreatic isoform was used as it has the same affinity for GKRP as liver GCK (30). The extracted enzyme was pure and at a concentration of 1.2 mg/ml, as determined by the Agilent 230 Protein kit (Agilent Technologies UK Ltd, Stockport, UK) and Bio-Rad Bradford reagent assay (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK), respectively. Three preparations each of FLAG-tagged human WT and P446L-GKRP were extracted based on a protocol previously described but without the use of a DEAE-sepharose ion-exchange resin (7). The extracted regulatory proteins were confirmed as being greater than 95% pure via Agilent analysis, and concentrations quantified as before (average 0.19 mg/ml for WT and 0.12 mg/ml for P446L-GKRP; n = 3). Storage buffer [0.7 m glycerol, 0.2 m KCl, 0.06 m Tris-HCl (pH 8), 5 mm dithiothreitol (DTT), 0.06 m glucose (GCK preparation only); all Sigma Aldrich Company Ltd] was added to recombinant GCK and GKRP in 1:1 volume ratio prior to snap-freezing and storage at -80degreesC. For initial regulatory protein preparations (n = 1), storage buffer including glucose was added to samples. As this affected competitive inhibition assays, storage buffer was changed using Vivaspin20 columns containing diafiltration cups (Sartorius Mechatronics, Epsom, UK) to one in which glucose was absent.
###end p 38
###begin title 39
GKRP assays
###end title 39
###begin p 40
###xml 301 302 301 302 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 411 412 411 412 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C9">9</xref>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C29">29</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C30">30</xref>
###xml 652 653 646 647 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 658 659 652 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 670 671 660 661 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 698 699 688 689 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 709 710 699 700 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 723 724 713 714 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 729 730 719 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 735 736 725 726 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 745 746 735 736 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 759 760 749 750 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1132 1133 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 1153 1154 1143 1144 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1249 1250 1231 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 672 678 <span type="species:ncbi:9913">bovine</span>
GKRP inhibition of GCK activity was determined spectrophotometrically using glucose 6-phosphate dehydrogenase (G6PDH)-linked assays (Sigma Aldrich Ltd). Experiments using both comparable activity/mg (amount of WT and P446L-GKRP used in each experiment inhibited 10 m U/ml GCK by the same extent at 5 mm glucose in the absence of the phosphate esters) (7) and equimolar concentrations (either 0, 50, 100 or 150 mm of both regulatory proteins used per assay) (9) were conducted. Assays were based on previously described protocols (7,29,30) but with the following modifications. Competitive inhibition assays were at 37degreesC, pH 7.1, and contained 2 mm MgCl2, 3.8 microm bovine serum albumin, 25 mm KCl, 25 mm HEPES, 0.5 mm NADP+, 1 mm ATP, 1 mm DTT, 0-100 mm glucose, 4 U/ml G6PDH, 10 m U/ml GCK and 1 U GKRP. All assay reagents (except GCK and GKRP which were generated in-house) were obtained from Sigma Aldrich Ltd. One m-unit of GCK was defined as that which converts 1 nmol substrate per minute, whereas one GKRP unit was defined as that which inhibits 10 m U/ml GCK by 50% under the standard assay conditions defined above (7). On average at 5 mm glucose, one GKRP unit resulted from 15.87 microg/ml of WT and 14.05 microg/ml of P446L-GKRP (n = 3 independent protein preparations). One GKRP unit of both WT and variant P446L regulatory protein were subsequently used per equimolar activity assay.
###end p 40
###begin p 41
###xml 121 122 121 122 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
F1P and F6P assays were performed using the same assay conditions as for competitive inhibition experiments, but only 5 mm glucose (7). Both phosphate esters were purchased from Sigma Aldrich Ltd.
###end p 41
###begin p 42
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP357C7">7</xref>
###xml 290 298 290 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">apparent</sub>
Ki (inhibitor dissociation constants) were determined from Dixon plots of 1/GCK activity versus [GKRP] as previously described (7) for the competitive inhibition assays. Plots of 1/GCK activity versus [F6P] or [F1P] were also used to determine apparent inhibitor dissociation constants, 'Kiapparent', from these experiments. As the phosphate esters are secondary regulators of GCK activity (act via the inhibitor GKRP), Dixon plots provided an insight into dissociation of the phosphate esters, GKRP and GCK, but could not be used to distinguish specifically between the individual components of these interactions.
###end p 42
###begin title 43
Gene expression analysis
###end title 43
###begin p 44
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 9 12 9 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 67 68 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1096 1100 1076 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCKR</italic>
###xml 1105 1108 1085 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 1170 1174 1150 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 1176 1179 1156 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B2M</italic>
###xml 1184 1188 1164 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTB</italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 124 129 <span type="species:ncbi:9606">human</span>
###xml 200 205 <span type="species:ncbi:9606">human</span>
###xml 299 304 <span type="species:ncbi:9606">human</span>
GCKR and GCK expressions were observed via qRT-PCR in human liver (n = 1), human islets (n = 2), human pancreas (n = 1) and human adipocytes (n = 1). All samples were part of a commercially available human RNA tissue panel (Clontech-Takara Bio Europe, Saint-Germain-en-Laye, France), except for the human islets which were collected as part of a previous study at Oxford University which had been conducted with full ethical consent. RNA samples were initially treated with DNase I (Applied Biosystems, Warrington, UK) to remove all genomic contamination. This was followed by random primed first-strand cDNA synthesis using 1 microg of each RNA sample and a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Reactions in which the enzyme was absent were also carried out to produce negative controls for the final qRT-PCR. cDNA was diluted 1/100 and 4 microl used in a total reaction volume of 10 microl [5.5 microl of Taqman gene expression master mix and 0.5 microl of the appropriate Taqman gene expression assay (both Applied Biosystems)] and each sample run in triplicate. GCKR and GCK expressions were made relative to three house-keeping genes (HPRT, B2M and ACTB), and normalized to the 1/100 dilution of the standard curve (for each gene-specific assay).
###end p 44
###begin title 45
Statistical analysis
###end title 45
###begin p 46
###xml 16 17 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Paired two-tail t-tests were used for statistical analysis of all assay data, with a cut-off value for statistical significance of 0.05.
###end p 46
###begin title 47
SUPPLEMENTARY MATERIAL
###end title 47
###begin p 48
.
###end p 48
###begin title 49
[Supplementary Data]
###end title 49
###begin title 50
FUNDING
###end title 50
###begin p 51
###xml 41 65 41 65 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Medical Research Council</funding-source>
###xml 80 85 80 85 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">81696</award-id>
This work was supported in Oxford by the Medical Research Council [Grant number 81696 to A.L.G.]. C.R. is a recipient of a European Foundation for the Study of Diabetes (EFSD) Albert Renold Travel Fellowship. Funding to pay the Open Access publication charges for this article was provided by MRC Grant Reference 81696.
###end p 51
###begin title 52
ACKNOWLEDGEMENTS
###end title 52
###begin p 53
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 175 182 <span type="species:ncbi:9581">Gibbons</span>
The authors thank Katy Brocklehurst for providing the human GKRP plasmid and are also grateful to both Katy Brocklehurst and Rick Davies for their technical advice, and Geoff Gibbons and Sandy Humphries for their invaluable input into the assay analysis.
###end p 53
###begin p 54
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 54
###begin title 55
REFERENCES
###end title 55
###begin article-title 56
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
###end article-title 56
###begin article-title 57
A common missense variant in the glucokinase regulatory protein gene (GCKR) is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations
###end article-title 57
###begin article-title 58
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes
###end article-title 58
###begin article-title 59
The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population
###end article-title 59
###begin article-title 60
Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes
###end article-title 60
###begin article-title 61
Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics
###end article-title 61
###begin article-title 62
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Differences in regulatory properties between human and rat glucokinase regulatory protein
###end article-title 62
###begin article-title 63
Binding of sorbitol 6-phosphate and of fructose 1-phosphate to the regulatory protein of liver glucokinase
###end article-title 63
###begin article-title 64
Identification of fructose 6-phosphate- and fructose 1-phosphate-binding residues in the regulatory protein of glucokinase
###end article-title 64
###begin article-title 65
###xml 92 95 <span type="species:ncbi:10116">rat</span>
Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain
###end article-title 65
###begin article-title 66
###xml 61 65 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Characterization of glucokinase regulatory protein-deficient mice
###end article-title 66
###begin article-title 67
A comparison of the utilization rates and hormone-releasing actions of glucose, mannose, and fructose in isolated pancreatic islets
###end article-title 67
###begin article-title 68
###xml 90 94 <span type="species:ncbi:10116">rats</span>
Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia
###end article-title 68
###begin article-title 69
Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein
###end article-title 69
###begin article-title 70
###xml 48 51 <span type="species:ncbi:10116">rat</span>
Heterologous expression and characterization of rat liver glucokinase regulatory protein
###end article-title 70
###begin article-title 71
Mutations in the glucokinase regulatory protein gene in 2p23 in obese French caucasians
###end article-title 71
###begin article-title 72
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human glucokinase regulatory protein (GCKR): cDNA and genomic cloning, complete primary structure, and chromosomal localization
###end article-title 72
###begin article-title 73
Species and tissue distribution of the regulatory protein of glucokinase
###end article-title 73
###begin article-title 74
The mechanism of sugar phosphate isomerization by glucosamine 6-phosphate synthase
###end article-title 74
###begin article-title 75
Involvement of the C terminus in intramolecular nitrogen channeling in glucosamine 6-phosphate synthase: evidence from a 1.6 A crystal structure of the isomerase domain
###end article-title 75
###begin article-title 76
The regulatory protein of glucokinase
###end article-title 76
###begin article-title 77
The SIS domain: a phosphosugar-binding domain
###end article-title 77
###begin article-title 78
Effectors of the regulatory protein acting on liver glucokinase: a kinetic investigation
###end article-title 78
###begin article-title 79
Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations
###end article-title 79
###begin article-title 80
Allosteric activators of glucokinase: potential role in diabetes therapy
###end article-title 80
###begin article-title 81
###xml 34 38 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression
###end article-title 81
###begin article-title 82
Correction of diabetic alterations by glucokinase
###end article-title 82
###begin article-title 83
Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme
###end article-title 83
###begin article-title 84
###xml 42 47 <span type="species:ncbi:9606">human</span>
Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein
###end article-title 84

